Skip to main content
. 2016 Nov 9;8(11):304. doi: 10.3390/v8110304

Table 1.

Host-virus interactions in RWV bioreactor-derived 3D aggregates.

Tissue Model Cell Lines Virus Virus Replication Host Response Reference
Neuronal NHNP VZV Productive infection No CPE [31]
Tonsil Primary cells HIV Productive infection Lymphocyte migration tracked [32]
Lymphoid P3HR-1 EBV Suppression of EBV reactivation ND [33]
P3HR-1
Daudi
Ramos
EBV Suppression of EBV reactivation ND [34]
BJAB
Raji
EBV Suppression of EBV reactivation Microgravity and radiation increased DNA damage in EBV positive cells [35]
Lung HBTC
BEAS-2B
SARS-CoV No SARS-CoV replication detected Vacuolization, mitochondria loss and chromatin alterations [36]
HBTC
BEAS-2B
RSV Productive infection Signs of cellular damage; mucus produced in 3D aggregates [37]
HBTC
BEAS-2B
RSV
PIV3
Productive infection Cytokine profile in 3D aggregates was similar to human airways from RSV- and PIV3-infected patients [30]
Liver Huh7 HCV Productive infection Expression and localization of TJ proteins enhance HCV infection [38]
PLC/PRF/5 HEV Productive infection No CPE [39]
Small Intestine INT-407 HuNoV Increase in viral RNA copies detected Vacuolization, shortening of apical microvilli, cell detachment from bead [40]
No HuNoV replication detected Clumping and detachment of cells from microcarrier beads [41]
No HuNoV replication detected No CPE [42,43]
Colon Caco-2 HuNoV Increase in HuNoV RNA copies detected Shortening of apical microvilli and formation of vacuoles [44]
No HuNoV replication detected No CPE [42,43]
CVB Productive infection Increased expression of proliferation and differentiation genes [24]
Placenta TBPC HCMV Productive infection ND [45]
JEG-3 VSV No VSV replication detected Resistance to infection mimics in vivo response to infection [26]
Vagina V19I HSV-1
HSV-2
Productive infection Mucosal epithelial barrier features mimic in vivo characteristics, aggregates are more resistant to HSV infection [28]

NHNP, normal human neural progenitor; VZV, Varicella zoster virus; HIV, human immunodeficiency virus; HCV, hepatitis C virus; EBV, Epstein–Barr virus; HEV, hepatitis E virus; CBV, Coxsackie B virus; HCMV, human cytomegalovirus; VSV, Vesicular stomatitis virus; HSV, herpes simplex virus; RSV, respiratory syncytial virus; PIV3, parainfluenza virus type 3; SARS- CoV, severe acute respiratory syndrome coronavirus; HuNoV, human norovirus; CPE, cytopathic effects; ND, not determined.